STOCK TITAN

Destination XL (DXLG) board to weigh $0.82 Zodiac tender offer against FullBeauty merger

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Destination XL Group, Inc. disclosed that its board is reviewing an unsolicited tender offer from Zodiac Partners II, LLC to purchase DXL shares at $0.82 per share in cash. The board is evaluating this offer with independent financial and legal advisors in light of its existing merger agreement with FullBeauty.

The board has not yet made a recommendation and has advised shareholders to take no action at this time. Within ten business days of Zodiac’s May 12, 2026 offer, DXL plans to file a Schedule 14D-9 with the SEC stating the board’s position, which will also be available on the company’s investor relations website.

Positive

  • None.

Negative

  • None.

Insights

DXL faces an unsolicited $0.82-per-share tender offer that will be weighed against an existing merger agreement.

Destination XL reports that Zodiac Partners II has launched a cash tender offer at $0.82 per share. The board is assessing this proposal alongside a previously signed merger agreement with FullBeauty, engaging independent financial and legal advisors to support its fiduciary review.

The outcome will depend on comparative economics and terms of the Zodiac offer versus the FullBeauty merger, as described in future SEC materials. The company plans to outline its recommendation in a Schedule 14D-9 within ten business days of the May 12, 2026 offer, giving shareholders a formal board view before they decide whether to tender.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Tender offer price $0.82 per share Cash tender offer by Zodiac Partners II for DXL shares
Offer date May 12, 2026 Commencement date of Zodiac’s tender offer
Board statement date May 22, 2026 Date DXL announced review of Zodiac tender offer
14D-9 response window Ten business days Timeframe to file Schedule 14D-9 after May 12, 2026 offer
Exhibit number 99.1 Press release about Zodiac tender offer review
tender offer financial
"unsolicited $0.82 per share in cash tender offer (the “Offer”) made by Zodiac Partners II, LLC"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Schedule 14D-9 regulatory
"by filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission"
Schedule 14D-9 is a filing with the U.S. Securities and Exchange Commission in which a company publicly states its response and recommendation to an outside bid to buy its shares (a tender offer). Think of it as the company’s advisory note to shareholders explaining whether to sell, keep, or seek alternatives, and why, with facts and reasoning. Investors rely on it to gauge management’s view of the offer’s fairness and the likely impact on value and strategy.
proxy statement regulatory
"In connection with the Merger, DXL intends to file a proxy statement (the “Proxy Statement”)"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
forward-looking statements regulatory
"this document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"DXL claims the protection provided for in the Private Securities Litigation Reform Act of 1995"
0000813298false00008132982026-05-222026-05-22

k

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 22, 2026

 

 

DESTINATION XL GROUP, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

01-34219

04-2623104

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

555 Turnpike Street

 

Canton, Massachusetts

 

02021

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 781 828-9300

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

DXLG

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

 

 

Item 7.01 Regulation FD Disclosure.

 

On May 22, 2026, Destination XL Group, Inc. (the “Company”) issued a press release regarding its review of an unsolicited tender offer from Zodiac Partners II. A copy of this press release is furnished herewith as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press release, dated May 22, 2026.

 

104

Cover Page Interactive Data File – The cover page interactive data file does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Destination XL Group, Inc.

 

 

 

 

Date:

May 22, 2026

By:

/s/ Robert S. Molloy

 

 

 

General Counsel and Secretary

 


img200863990_0.jpg

Exhibit 99.1

 

Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II

 

No Shareholder Action Required at this Time

 

CANTON, Mass., May 22, 2026 -- Destination XL Group, Inc. (“DXL”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today issued the following statement with respect to the unsolicited $0.82 per share in cash tender offer (the “Offer”) made by Zodiac Partners II, LLC ("Zodiac") on May 12, 2026:

 

The DXL Board of Directors is carefully evaluating the Offer with its independent financial and legal advisors in furtherance of its fiduciary duties and in light of the Company’s merger agreement with FBB Holdings I, Inc. (“FullBeauty”). The Board will make a recommendation to shareholders in due course.

 

DXL shareholders are advised to take no action at this time pending the Board's review of the Offer.

 

DXL will advise shareholders of the Board's position regarding the Offer within ten business days of the date of Zodiac’s Offer by filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission (the "SEC"), which will also be published on DXL's investor relations website at investor.dxl.com.

 

Advisors

 

Guggenheim Securities, LLC is acting as financial advisor to DXL, Greenberg Traurig, LLP is acting as its legal advisor and Joele Frank, Wilkinson Brimmer Katcher is serving as its strategic communications advisor.

 

About Destination XL Group, Inc.

 

Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, and an e-commerce website, DXL.COM, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Global Market under the symbol "DXLG." For more information, please visit the Company's investor relations website: https://investor.dxl.com.

 

Investor Contact:

Investor.relations@dxlg.com

603-933-0541

 


 

Important Information about the Zodiac Tender Offer and Where to Find It

 

DXL intends to file a solicitation/recommendation statement on Schedule 14D-9 with respect to the tender offer with the Securities and Exchange Commission (the “SEC”) within 10 business days of the commencement of the Zodiac tender offer. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE SOLICITATION/RECOMMENDATION STATEMENT AND ANY OTHER RELEVANT DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER. Investors and security holders may obtain free copies of the solicitation/recommendation statement (when available) as well as other filings by DXL, without charge, at the SEC’s website, http://www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

 

 

Important Information about the Merger and Where to Find It

 

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This communication may be deemed to be solicitation material in respect of the proposed merger (the “Merger”) between DXL and FullBeauty. In connection with the Merger, DXL intends to file a proxy statement (the “Proxy Statement”), which will be distributed to the stockholders of DXL in connection with their votes on the issuance of DXL Common Stock in the Merger. Investors and security holders are advised to read the Proxy Statement when it becomes available (and any other documents filed with the Securities and Exchange Commission (the “SEC”) in connection with the Merger or incorporated by reference into the Proxy Statement) because such documents will contain important information regarding the Merger and related matters. Investors and security holders will be able to obtain these documents, and any other documents DXL has filed with the SEC, free of charge at the SEC’s website, www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

 

 

Participants in the Solicitation

 

DXL and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about DXL’s directors and executive officers, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in DXL’s proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on June 30, 2025, including under the headings “Director Compensation,” “Compensation Discussion and Analysis,” “Executive Compensation,” “Security Ownership of Management.” To the extent holdings of DXL Common Stock by the directors and executive officers of DXL have changed from the amounts of DXL Common Stock held by such persons as reflected therein, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership of Securities on Form 5, in each case filed with the SEC, including the Form 4s filed by each of the non-executive directors on August 6, 2025, the Form 4s filed by each of the executive officers on September 3, 2025 and the Form 4s filed by each of the non-executive directors on November 5, 2025.


 

 

FBB and its chief executive officer may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about FBB and its chief executive officer can be found in the Form 8-K filed by DXL with the SEC on December 11, 2025.

 

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement regarding the Merger when it becomes available. Free copies of this document may be obtained as described above.

 

 

Forward-Looking Statements

 

In addition to historical information, this document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including statements as to the expected timing, are based on current expectations, estimates and beliefs of DXL management. Words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks” and variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature. With respect to any such forward-looking statements, DXL claims the protection provided for in the Private Securities Litigation Reform Act of 1995. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. These forward-looking statements could be affected by factors including, without limitation, the risks and factors detailed in reports filed with the SEC by DXL from time to time, including those discussed under the heading “Risk Factors” in DXL’s most recently filed Annual Report on Form 10-K. These documents are available through our website or through the SEC’s Electronic Data Gathering and Analysis Retrieval (EDGAR) system at http://www.sec.gov. Neither DXL undertakes any duty to update any forward-looking statements contained herein, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.


FAQ

What did Destination XL Group (DXLG) announce regarding the Zodiac tender offer?

Destination XL announced that its board is reviewing an unsolicited Zodiac Partners II cash tender offer at $0.82 per share. The company is evaluating it with independent advisors and will issue a formal recommendation through a Schedule 14D-9 filing.

How much is Zodiac Partners offering per share for Destination XL (DXLG)?

Zodiac Partners II launched an unsolicited tender offer to acquire Destination XL shares at $0.82 per share in cash. The board is currently evaluating this proposal in light of its existing merger agreement with FullBeauty and has not yet made a recommendation.

Should Destination XL (DXLG) shareholders take any action on the Zodiac tender offer now?

DXL’s board has advised shareholders to take no action at this time regarding the Zodiac tender offer. The company will provide its formal position in a Schedule 14D-9 filed with the SEC within ten business days of the offer date.

When will Destination XL (DXLG) issue its recommendation on the Zodiac tender offer?

Destination XL plans to file a Schedule 14D-9 with the SEC within ten business days of Zodiac’s May 12, 2026 offer. That filing will include the board’s recommendation and will also be available on DXL’s investor relations website.

How does the Zodiac tender offer relate to Destination XL’s merger with FullBeauty?

Destination XL’s board is reviewing the unsolicited Zodiac tender offer in light of its existing merger agreement with FullBeauty. Advisors are helping the board assess both transactions before it issues a recommendation to shareholders via Schedule 14D-9.

Where can investors find official documents on the Destination XL (DXLG) tender offer and merger?

Investors can access all relevant documents, including the Schedule 14D-9 and merger proxy statement when available, on the SEC’s website at sec.gov and on Destination XL’s investor site, investor.dxl.com, where filings are posted free of charge.

Filing Exhibits & Attachments

2 documents